First report of interruption of mast cell degranulation and endothelial cells activation by anti-inflammatory drugs controlling the acute response provoked by Pseudoplatystoma fasciatum fish venom

Autor(es)

Lopes-Ferreira, Monica ^[1] ; Gomes, Eduardo Martins ^[1] ; Bruni, Fernanda Miriani ^[1] ; Ferreira, Marcio Jose ^[1] ; Charvet, Patricia ^[2] ; Lima, Carla ^[1]

Afiliação do(s) autor(es)

^[1] Butantan Inst, Immunoregulat Unit, Special Lab Appl Toxinol Cepid Fapesp, BR-05503009 Sao Paulo - Brazil

^[2] SENAI, Dept Reg Parana, Curitiba, Parana - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Toxicon; v. 90, p. 237-248, NOV 2014.
• Citações Web of Science: 8

Resumo

This is the first report describing in mice the envenoming that possible to occur in humans provoked by Pseudoplatystomafasciatum and evaluated the different class of mediators involved in the inflammatory injury, identifying important targets for drugs intervention. First we demonstrate that P. fasciatum venom induces an acute inflammatory response characterized by the recruitment of immune cells into peripheral tissues choreographed by chemoattractants including lipid mediators (LTB4 and PGE(2)), cytokines (IL-1 beta and TNF-alpha), and chemokines (KC and MCP-1). Intravital microscopy studies showed that only high dose (60 mu g) of venom promoted hemodynamic changes inducing an abundant number of thrombi of varying sizes in venules leading to transient venular stasis with reduced blood flow. We found that serotonin, leukotrine and prostaglandin are involved in edematogenic and nociceptive responses, since a selective COX-2 inhibitor, a non-specific inhibitor for cytokines and COX-2, and a non-selective 5-HT receptor antagonist were able to reduce both symptoms. In conclusion, our data show that the main symptoms of acute inflammation as pain provoked by P. fasciatum fish venom could be well managed by available drugs as COX-2 inhibitors as well dexamethasone or non-selective 5-HT receptor antagonists. (C) 2014 Elsevier Ltd. All rights reserved. (AU)

• Processo FAPESP: 98/14307-9 - Center for Applied Toxinology
• Beneficiário: Hugo Aguirre Armelin
• Modalidade de apoio: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs